Industry Outlook

Virus filtration market accounted for a market value of US$ 2,764.1 Mn in 2020 and is projected to grow at a CAGR of 9.5% during the forecast period from 2023 to 2030. Virus filtration through membranes with pores.

"Virus filters & filtration systems segment is the largest product segment and expected to maintain its dominance throughout the forecast period"

In 2020, virus filters & filtration systems accounted for the largest market, as these are highly expensive compared to kits & reagents, and services. The virus filtration systems for large water purifying and pharmaceutical industrial plants are huge and designed on customized requirement due to which the cost of these products is high and expected to remain high throughout the forecast period. However, kits & regents was expected as the fastest growing segment throughout the forecast period due to high demand and it’s reordered repeatedly till the filtration system is in use.

"Increasing development in healthcare industry of developing countries from Asia Pacific such as India & China will assist the demand growth throughout the forecast period"

Asia Pacific identified as the fastest-growing virus filtration systems market due to increase in number of biotechnology & pharmaceutical industries, adoption of stringent regulatory policies against quality of healthcare products, and increasing awareness related to virus-specific risk associated with vaccine or injectable production. India and China are the key countries that will experience this exceptional growth from 2023 to 2030.

The key players included in the market study investigated based on attributes such as financial information, product portfolio, recent market updates, and important market strategies. This report also covers attractive investment proposition analyzed with an exhaustive geographical research based on PESTEL analysis. The companies profiled in the report are Merck KGaA, Thermo Fisher Scientific, Inc., Medical Respiratory Devices PendoTECH, Lonza, Sartorius AG, Charles River Laboratories, General Electric, Asahi Kasei Corporation, Danaher, PendoTECH, and Lonza among others.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Virus Filtration market are as follows:

Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users and consumption volume, price and value.
Geographical revenues generate by countries considered in the report
Micro and macro environment factors that are currently influencing the Virus Filtration market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

ATTRIBUTE	DETAILS
Research Period	2022-2032
Base Year	2023
Forecast Period	2024-2032
Historical Year	2022
Unit	USD Million
Segmentation
	Product Virus Filters & Filtration Systems Kits & Reagents Services
	Application Biological Vaccines and Therapeutics Blood and Blood Products Cellular and Gene Therapy Products Tissue and Tissue Products Stem Cell Products Medical Device Others (Air Purification, & Water Purification)
	End-Users Pharmaceutical & Biotechnology Contract Research Organizations Academic Research Institutes Medical Device Companies
	Region Segment (2022-2032; US$ Million) North America U.S. Canada Rest of North America UK and European Union UK Germany Spain Italy France Rest of Europe Asia Pacific China Japan India Australia South Korea Rest of Asia Pacific Latin America Brazil Mexico Rest of Latin America Middle East and Africa GCC Africa Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Virus Filtration market?
What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
Estimated forecast and market projections up to 2032.
Which segment accounts for the fastest CAGR during the forecast period?
Which market segment holds a larger market share and why?
Are low and middle-income economies investing in the Virus Filtration market?
Which is the largest regional market for Virus Filtration market?
What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
Which are the key trends driving Virus Filtration market growth?
Who are the key competitors and what are their key strategies to enhance their market presence in the Virus Filtration market worldwide?